April 2025
1. MO X, Meng K, Xu B, Li Z, et al
   Nat10-mediated N4-acetylcytidine modification enhances Nfatc1 translation to exacerbate osteoclastogenesis in postmenopausal osteoporosis.
   Proc Natl Acad Sci U S A. 2025;122:e2423991122.
   

   >> Share

   
   March 2025
2. ZHANG W, Li W, Du J, Yang C, et al
   Dnmt3a-mediated hypermethylation of FoxO3 promotes redox imbalance during osteoclastogenesis.
   Proc Natl Acad Sci U S A. 2025;122:e2418023122.
   

   >> Share

   
   January 2025
3. LI S, Sun W, Li S, Zhu L, et al
   Tamsulosin ameliorates bone loss by inhibiting the release of Cl(-) through wedging into an allosteric site of TMEM16A.
   Proc Natl Acad Sci U S A. 2025;122:e2407493121.
   

   >> Share

   
   December 2024
4. LANZOLLA G, Sabini E, Beigel K, Khan MP, et al
   Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiency.
   Proc Natl Acad Sci U S A. 2024;121:e2416004121.
   

   >> Share

   
   November 2024
5. DU Y, Chen H, Zhou L, Guo Q, et al
   REGgamma is essential to maintain bone homeostasis by degrading TRAF6, preventing osteoporosis.
   Proc Natl Acad Sci U S A. 2024;121:e2405265121.
   

   >> Share

   
   April 2024
6. 
   Correction for Keum et al., Heterogeneous osteoimmune profiles via single-cell transcriptomics in osteoporotic patients who fail bisphosphonate treatment.
   Proc Natl Acad Sci U S A. 2024;121:e2404416121.
   

   >> Share

   
   February 2024
7. KEUM BR, Kim HJ, Lee J, Lee M, et al
   Heterogeneous osteoimmune profiles via single-cell transcriptomics in osteoporotic patients who fail bisphosphonate treatment.
   Proc Natl Acad Sci U S A. 2024;121:e2316871121.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share